Analysis of risk factors and different treatments for infections caused by carbapenem-resistant Acinetobacter baumannii in Shaanxi, China

被引:0
|
作者
He, Xiaoliang [1 ]
Tang, Jin [1 ]
He, Sanjun [1 ]
Huang, Xiaoxia [1 ]
机构
[1] Hanzhong Cent Hosp, Dept Clin Lab, 22 Kangfu Rd, Hanzhong, Shaanxi, Peoples R China
关键词
Molecular epidemiology; Drug resistance; Mortality; Prognosis; KLEBSIELLA-PNEUMONIAE; CLINICAL ISOLATE; MORTALITY; PREDICTORS; SULBACTAM; EVOLUTION; OUTCOMES;
D O I
10.1186/s12879-024-10036-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background The global threat of Carbapenem-resistant Acinetobacter baumannii (CRAB) has intensified as resistance to carbapenems continues to rise in recent decades. We aimed to explore risk factors, molecular epidemiology, and antimicrobial therapy of CRAB infection. Methods The clinical data of 110 patients infected with A. baumannii from December 2021 to December 2022 were retrospectively analyzed. Patients were divided into a carbapenem-resistance group (55 patients) and carbapenem-sensitive group (CSAB; 55 patients) based on resistance to carbapenem, and the risk factors of patients infected with CRAB were analyzed. Fifty-five patients with CRAB infection who received antimicrobial therapy were divided into a combination therapy group (45 patients) and a monotherapy group (10 patients), and differences between the two groups were compared. Whole-genome sequencing analysis was performed to assess resistance genes. Phylogenetic analysis was performed to explore the characteristics of CRAB isolates. Results Among the total 110 patients, the rate of poor prognosis in the CRAB group was 43.6% (24/55). Mechanical ventilation (odds ratio [OR] = 5.364, 95% confidence interval [CI] 1.462-19.679, P = 0.011) and puncture (OR = 19.935, 95% CI 1.261-315.031, P = 0.012) were independent risk factors for CRAB infection. Of 55 patients in the antimicrobial regimen study, 45 received combination therapy (including dual, triple, or quadruple antibiotic therapy) and 10 received monotherapy. Univariate analysis revealed significant differences between the combination group and monotherapy group for admission to the intensive care unit and wound infection (P < 0.05). The CRAB strains of 26 patients taking carbapenem-based combination therapy were mainly ST208, ST1968, and ST195, among which patients with ST1968 strains had higher 28-day mortality. Furthermore, the blaOXA-23 gene was harbored in ST1968, ST195, and ST208. Conclusions Mortality was significantly higher in patients infected with CRAB than with CSAB. Mechanical ventilation and puncture were independent risk factors in predicting CRAB infections. The distribution of CRAB was dominated by ST208, ST1968, and ST195, among which patients with ST1968 had higher 28-day mortality. The blaOXA-23 gene appears to be widely disseminated.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Risk Factors for Development and Mortality of Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
    Li, Liubing
    Chen, Dubo
    Liu, Pingjuan
    Dai, Luqi
    Tang, Zhaoxia
    Yi, Siting
    Ye, Mengmin
    INFECTION AND DRUG RESISTANCE, 2024, 17 : 5699 - 5706
  • [2] Incidence of infections caused by carbapenem-resistant Acinetobacter baumannii
    Rossi, Iara
    Royer, Sabrina
    Ferreira, Melina Lorraine
    Campos, Paola Amaral
    Fuga, Bruna
    Melo, Gabriel Nogueira
    Machado, Luiz Gustavo
    Resende, Daiane Silva
    Batistao, Deivid
    Urzedo, Jane Eire
    Gontijo-Filho, Paulo P.
    Ribas, Rosineide Marques
    AMERICAN JOURNAL OF INFECTION CONTROL, 2019, 47 (12) : 1431 - 1435
  • [3] Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii
    Zhang, Siqin
    Di, Lingfang
    Qi, Yan
    Qian, Xiang
    Wang, Siwei
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [4] Treating carbapenem-resistant Acinetobacter baumannii infections
    Giannella, Maddalena
    Viale, Pierluigi
    LANCET INFECTIOUS DISEASES, 2023, 23 (09): : 994 - 995
  • [5] Multidrug and carbapenem-resistant Acinetobacter baumannii infections: Factors associated with mortality
    Hernandez-Torres, Alicia
    Garcia-Vazquez, Elisa
    Gomez, Joaquin
    Canteras, Manuel
    Ruiz, Joaquin
    Yaguee, Genoveva
    MEDICINA CLINICA, 2012, 138 (15): : 650 - 655
  • [6] Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections
    Iovleva, Alina
    Fowler Jr, Vance G.
    Doi, Yohei
    DRUGS, 2025, 85 (01) : 21 - 40
  • [7] Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection
    Kim, Y. J.
    Kim, S. I.
    Kim, Y. R.
    Hong, K. W.
    Wie, S. H.
    Park, Y. J.
    Jeong, H.
    Kang, M. W.
    EPIDEMIOLOGY AND INFECTION, 2012, 140 (01): : 137 - 145
  • [8] Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia
    Liu, Chang-Pan
    Shih, Shou-Chuan
    Wang, Nai-Yu
    Wu, Alice Y.
    Sun, Fang-Ju
    Chow, Shan-Fan
    Chen, Te-Li
    Yan, Tsong-Rong
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (06) : 934 - 940
  • [9] Risk factors for infection after carbapenem-resistant Acinetobacter baumannii colonization
    Peghin, Maddalena
    Givone, Filippo
    de Martino, Maria
    Ali, Raja Waqar
    Graziano, Elena
    Isola, Miriam
    Grossi, Paolo Antonio
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (11) : 2191 - 2199
  • [10] ANALYSIS OF DRUG RESISTANCE OF CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN CHILDREN AND ITS RISK FACTORS
    Huang, YuanYuan
    Qian, Min
    Zhang, Sai
    Xu, JianCheng
    Li, HaiBo
    Chen, Yang
    Zhou, Qi
    ACTA MEDICA MEDITERRANEA, 2019, 35 (06): : 3417 - 3422